DIESSE Diagnostica Senese S.p.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
DIESSE Diagnostica Senese S.p.A. - overview
Established
1980
Location
Siena, -, Italy
Primary Industry
Medical Devices & Equipment
About
DIESSE Diagnostica Senese S. p. A. , based in Italy, specializes in the development and manufacturing of diagnostic systems and reagents for healthcare, facilitating efficient diagnostic testing worldwide.
DIESSE Diagnostica Senese S. p. A. focuses on providing diagnostic solutions in the healthcare sector.
Founded in 1980 in Siena, Italy, the company has successfully completed 2 deals, with the most recent deal occurring on January 24, 2025. The CEO of the company is Massimiliano Boggetti. DIESSE Diagnostica Senese S. p.
A. specializes in developing and manufacturing diagnostic systems and reagents primarily for the healthcare industry. Its core products include advanced diagnostic platforms such as the VES-MATIC, CHORUS, AUTO-DAT, ENZYWELL, and iRAPID. These products are designed for hospital and laboratory use, enabling a wide array of tests for infectious diseases, immunology, and other critical health assessments.
DIESSE markets its offerings across Europe, Asia, and Latin America, providing essential diagnostic information to healthcare professionals and institutions. The company generates revenue through direct sales to healthcare institutions and partnerships with distributors, supplying diagnostic systems and reagents for routine and specific medical diagnostics. In January 2025, Fremman Capital acquired DIESSE Diagnostica Senese S. p.
A. from ARCHIMED. This acquisition is expected to enhance DIESSE's growth and expansion plans. The company aims to launch new products while targeting expansion into new markets, bolstered by the recent funding.
Current Investors
Fremman Capital, Archimed
Primary Industry
Medical Devices & Equipment
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Medical Equipment Distributors
Website
www.diesse.it
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
DIESSE Diagnostica Senese S.p.A. - timeline of key events
DIESSE Diagnostica Senese S.p.A. - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 21,417,187 | 22,185,724 | 22,556,587 | 20,610,424 | 21,331,831 | 20,528,264 | 20,414,242 | 21,790,698 | 23,277,240 | 21,914,997 | 24,385,001 | 26,342,872 | - | - | - |
| % Revenue Growth (YoY) | - | 3.6% | 1.7% | (8.6%) | 3.5% | (3.8%) | (0.6%) | 6.7% | 6.8% | (5.9%) | 11.3% | 8.0% | - | - | - |
| EBITDA (USD) | 3,134,918 | 4,033,893 | 2,223,687 | 2,312,970 | 3,421,900 | 1,744,245 | 2,089,434 | 3,936,958 | 5,207,996 | 4,887,581 | 6,478,328 | 6,773,736 | - | - | - |
| Operating Income (USD) | 2,300,031 | 3,325,529 | 1,338,997 | 1,303,119 | 2,366,812 | 838,883 | 1,064,464 | 2,972,247 | 3,974,128 | 3,514,114 | 3,097,923 | 3,314,675 | - | - | - |
| Operating Margin | 10.7% | 15.0% | 5.9% | 6.3% | 11.1% | 4.1% | 5.2% | 13.6% | 17.1% | 16.0% | 12.7% | 12.6% | - | - | - |
| % EBITDA Margin | 14.6% | 18.2% | 9.9% | 11.2% | 16.0% | 8.5% | 10.2% | 18.1% | 22.4% | 22.3% | 26.6% | 25.7% | - | - | - |
| NET Income (USD) | 4,005,780 | 1,728,831 | 400,735 | 203,503 | (349,357) | (4,262,923) | 401,256 | 751,625 | 2,481,077 | 2,159,821 | 1,446,907 | 1,600,142 | - | - | - |
| % Net Margin | 18.7% | 7.8% | 1.8% | 1.0% | (1.6%) | (20.8%) | 2.0% | 3.4% | 10.7% | 9.9% | 5.9% | 6.1% | - | - | - |
DIESSE Diagnostica Senese S.p.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Corporate Carve Out, Secondary Buyout | Completed | DIESSE Diagnostica Senese S.p.A. | - | ||||||||
| Corporate Carve Out | Completed | DIESSE Diagnostica Senese S.p.A. | - |
Displaying 1 - 2 of 2
DIESSE Diagnostica Senese S.p.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.